Testing effectiveness (Phase 2)UnknownNCT02149160
What this trial is testing
Study to Assess the Safety, Tolerability, and Pharmacodynamic (PD) Effects of FRM-0334 in Subjects With Prodromal to Moderate Frontotemporal Dementia With Granulin Mutation
Who this might be right for
Granulin Mutation
FORUM Pharmaceuticals Inc 30